(GHYB) Goldman Sachs Access High - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US3814304537

High-Yield, Corporate Bonds, ETF, Index-Based

Description: GHYB Goldman Sachs Access High

The Goldman Sachs Access High Yield Corporate Bond ETF (GHYB) is designed to track the performance of the FTSE US High-Yield Market Index, utilizing a proprietary methodology developed by Goldman Sachs Asset Management (GSAM). By investing at least 80% of its assets in securities included in this underlying index, the fund aims to provide investors with exposure to the high-yield corporate bond market.

As a high-yield bond ETF, GHYB is positioned to capitalize on the income-generating potential of non-investment-grade corporate bonds. The funds underlying index is likely comprised of a diversified portfolio of high-yield bonds issued by U.S. corporations, offering a broad representation of the domestic high-yield market.

Analyzing the funds recent price action, we observe a bullish trend, with the 20-day SMA (44.17) and 50-day SMA (43.89) indicating a positive momentum. The current price (44.72) is near the 52-week high (44.75), suggesting a strong upward trend. The ATR (0.40) translates to a daily volatility of 0.90%, indicating a relatively stable trading environment.

Considering the funds AUM (108.56M USD), we can infer that GHYB has a moderate level of investor interest. While not a behemoth in terms of assets under management, the fund has a sufficient scale to maintain liquidity and support its investment objective.

Based on the technical and fundamental data, our forecast suggests that GHYB is poised for continued growth, driven by the ongoing demand for high-yield bonds in a low-interest-rate environment. With the 200-day SMA (43.53) providing a support level, we anticipate the funds price to potentially reach 45.50 within the next quarter, representing a 1.7% upside from current levels. However, investors should remain vigilant, as changes in market sentiment or interest rates could impact the funds performance.

Additional Sources for GHYB ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

GHYB ETF Overview

Market Cap in USD 90m
Category High Yield Bond
TER 0.34%
IPO / Inception 2017-09-05

GHYB ETF Ratings

Growth Rating 54.0
Fundamental -
Dividend Rating 78.3
Rel. Strength 8.59
Analysts -
Fair Price Momentum 46.05 USD
Fair Price DCF -

GHYB Dividends

Dividend Yield 12m 6.51%
Yield on Cost 5y 8.10%
Annual Growth 5y 4.32%
Payout Consistency 96.7%
Payout Ratio %

GHYB Growth Ratios

Growth Correlation 3m 95.6%
Growth Correlation 12m 87.1%
Growth Correlation 5y 54.4%
CAGR 5y 4.97%
CAGR/Max DD 5y 0.31
Sharpe Ratio 12m 2.26
Alpha 4.33
Beta 0.189
Volatility 4.85%
Current Volume 3.5k
Average Volume 20d 13k
What is the price of GHYB shares?
As of July 01, 2025, the stock is trading at USD 45.37 with a total of 3,519 shares traded.
Over the past week, the price has changed by +0.78%, over one month by +1.90%, over three months by +3.83% and over the past year by +10.73%.
Is Goldman Sachs Access High a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, Goldman Sachs Access High (NYSE ARCA:GHYB) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 53.99 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of GHYB is around 46.05 USD . This means that GHYB is currently overvalued and has a potential downside of 1.5%.
Is GHYB a buy, sell or hold?
Goldman Sachs Access High has no consensus analysts rating.
What are the forecasts for GHYB share price target?
According to our own proprietary Forecast Model, GHYB Goldman Sachs Access High will be worth about 50.2 in July 2026. The stock is currently trading at 45.37. This means that the stock has a potential upside of +10.67%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 50.2 10.7%